Cross-Border Deals: The Right Prescription for Animal Health
|As the humanization of pets continues and pet lifespans grow longer, investment opportunities in animal health abound. While most animal health companies will first look for growth within their own borders, global consolidation and expansion is rising in popularity because companies are struggling to grow revenue close to home and sector trends and attributes are similar across global markets.|
Lincoln International experts in the animal health sector share their perspectives on considerations for investors interested in cross-border mergers and acquisitions in the space.
- Click here to download a printable version of this perspective.
Subsector Consolidation to Watch
In the diverse world of animal health, four subsectors in particular have been active in exploring cross-border consolidation—pharmaceutical manufacturers, diagnostic and lab organizations, veterinary hospitals and distributors.
Five large pharmaceutical players dominate the animal health manufacturing market—Merck, Elanco, Ceva Animal Health, Zoetis and Boehringer Ingelheim. With antitrust regulations preventing these companies from making additional large acquisitions in the pharmaceutical markets, these players are forced to look outside their core businesses and core geographies to make acquisitions that will move the needle and continue to push growth.
Diagnostic and lab organizations are in similar positions. Mars, Heska Corporation, Zoetis and Idexx Laboratories dominate the diagnostic and lab sector and need to expand their geographic reach and diversify their capabilities to continue their organic growth. For example, in 2020 U.S.-based Zoetis acquired UK-based Virtual Recall to offer improved service and communication offerings to veterinary practices. The driver was partly diversification but also to expand relationships with the vet and be seen as a service ‘partner,’ rather than someone pushing a product or a drug—driving growth in their core business through the relationship. Additionally, Heska entered Europe in 2020 with the acquisition of Scil from Covetrus.
For veterinary hospitals, consolidation has occurred at a rapid clip and at some point players will need to look across borders to continue to grow. This is especially true in the UK where significant consolidation has already occurred, leading to searches for targets in Europe with providers like Vet Partners, IVC, Mars and recently Medivet, all spending time and money to grow their European footprint.
Distributors are feeling the margin pressure from the large pharmaceutical manufacturers supplying the product and from the continued consolidation of the veterinary hospitals buying the product. Distributors will have to diversify their current business models if they are to remain competitive.
As corporates look to achieve economies of scale, they need to evaluate geographic restrictions and diversify—in both their geographic location and offerings. For private equity investors, who are likely to create platforms in a singular animal health subsector, geographic diversification is key.
Lincoln International identified the following items to consider for investors interested in cross-border M&A:
To find success, those interested in pursuing consolidation in the animal health space need to work with advisors that have global reach and not only understand the pet space but also healthcare holistically. Connect with Lincoln International bankers to learn how their global network and industry knowledge can help you today.
Meet Professionals with Complementary Expertise
The Pharmaceutical Journal | Is Amazon Really a Threat to the UK Pharmacy Market?
Matthew Lee, Managing Director at Lincoln International joins the Pharmaceutical Journal deputy news editor, Carolyn Wickware, in a recent episode of The PJ Pod to share his thoughts on the… Read More
Whitepaper: 2021 Outlook for Value-Based Care and the Self-Insured Employer Marketplace
Numerous efforts to transition the U.S. healthcare system to a value-based care construct have been attempted during the past couple decades, including top-down initiatives such as accountable care organizations, with… Read More
Animal Health in the UK: Insights from the LaingBuisson Investing in Healthcare Conference
Pet ownership in the UK increased during the pandemic as animals provided comfort and companionship that individuals lacked during lockdown. Matthew Lee, Managing Director at Lincoln International, joined other industry… Read More
Navigating the Companion Animal Sector: Pet & Animal Health Investment
Pet ownership has been steadily rising in recent years as people around the world brought companion animals into their homes. Against the backdrop of the COVID-19 pandemic, even more consumers… Read More
Recent Transactions in Healthcare
Lincoln International is pleased to announce that KIMS Hospital has been sold to LycaHealth
Lincoln International is pleased to announce that ARK Agency has been sold to OPEN Health, a portfolio company of Amulet Capital Partners
Lincoln International is pleased to announce that Hg has madea strategic investment in HHAeXchange
Lincoln International is pleased to announce that Bridges Fund Management has sold The Vet to CVS Group plc
Lincoln is pleased to announce that Linsalata Capital Partners has sold Home Helpers to RiverGlade Capital
Lincoln International is pleased to announce that it has advised H&T Presspart on the acquisition of novelex AG from Liberta Partners
Lincoln International is pleased to announce the merger of Optovue with Luneau Technology
Lincoln International is pleased to announce that OPEN Health, a portfolio company of Amulet Capital Partners, has acquired Spirit Medical Communications